523 results on '"Cho, Kathleen R."'
Search Results
52. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group
53. Epithelial Tumors of the Ovary
54. HRAS mutations are frequent in inverted urothelial neoplasms
55. Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma
56. Sox9 Induction, Ectopic Paneth Cells, and Mitotic Spindle Axis Defects in Mouse Colon Adenomatous Epithelium Arising From Conditional Biallelic Apc Inactivation
57. Type I to Type II Ovarian Carcinoma Progression: Mutant Trp53 or Pik3ca Confers a More Aggressive Tumor Phenotype in a Mouse Model of Ovarian Cancer
58. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.
59. High‐grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease
60. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival
61. Molecular Biology
62. Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival
63. Next-Generation Sequencing of Tubal Intraepithelial Carcinomas
64. Genetic Alterations in Colorectal Tumors
65. Microscopic extraovarian sex cord proliferations: an undescribed phenomenon
66. NIH3T3 Cells Expressing the Deleted in Colorectal Cancer Tumor Suppressor Gene Product Stimulate Neurite Outgrowth in Rat PC12 Pheochromocytoma Cells
67. Identification of a Chromosome 18q Gene That is Altered in Colorectal Cancers
68. Engineering an Intracellular Pathway for Major Histocompatibility Complex Class II Presentation of Antigens
69. p53-Dependent G 1 Arrest Involves pRB-Related Proteins and is Disrupted by the Human Papillomavirus 16 E7 Oncoprotein
70. Human Papillomavirus 16 E6 Expression Disrupts the p53-Mediated Cellular Response to DNA Damage
71. Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research
72. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
73. Commd1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion
74. Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma
75. Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins
76. Serous Tubal Intraepithelial Carcinoma or Not? Metastases to Fallopian Tube Mucosa Can Masquerade as In Situ Lesions
77. Mouse Model of Human Ovarian Endometrioid Adenocarcinoma Based on Somatic Defects in the Wnt/β-Catenin and PI3K/Pten Signaling Pathways
78. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival
79. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression
80. Surface Epithelial Tumors of the Ovary
81. Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix
82. A 2-D liquid separations/mass mapping method for interlysate comparison of ovarian cancers
83. Abstract B50: Direct interrogation of the incessant ovulation hypothesis in a high-fidelity mouse model of high-grade serous cancer
84. Abstract IA14: Integrated molecular characterization of the genome, transcriptome, and immune microenvironment in oviductal high-grade serous carcinomas arising in genetically engineered mice
85. Abstract B65: Defining the tumor immune landscape in a mouse model of high-grade serous carcinoma
86. Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts
87. Gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin
88. Abstract AP16: MODELING ENDOMETRIOID AND HIGH GRADE SEROUS CARCINOMAS IN THE MOUSE USING CRISPR/CAS9-MEDIATED SOMATIC GENE EDITING IN FALLOPIAN TUBE EPITHELIUM
89. Abstract GMM-061: MOLECULAR CHARACTERIZATION OF MOUSE MODELS OF HIGH-GRADE SEROUS CARCINOMA ARISING IN THE OVIDUCT
90. COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion
91. Intravascular histiocytosis presenting with extensive vulvar necrosis
92. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project : Guidelines From the Special Techniques and Ancillary Studies Group:Guidelines From the Special Techniques and Ancillary Studies Group
93. A model-based scan statistic for identifying extreme chromosomal regions of gene expression in human tumors
94. Cancer: Cell survival guide
95. Expression of a homologue of the deleted in colorectal cancer (DCC) gene in the nervous system of developing Xenopus embryos
96. P53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein
97. Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells
98. Restored Expression of Fragile Histidine Triad Protein and Tumorigenicity of Cervical Carcinoma Cells
99. Cervical Mesonephric Adenocarcinoma With Novel FGFR2 Mutation
100. Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.